Life Technologies Announces SFDA Clearance for its 3500xL Dx Genetic Analyzer in China and the Launch of 10 Assays from its Joint Venture with Daan Gene
SHANGHAI, China, March 27, 2013 /PRNewswire/ — Life Technologies Corporation today announced that its Applied Biosystems 3500xL Dx Genetic Analyzer has been approved by China’s State Food and Drug Administration (SFDA) for clinical diagnostic use in China and the launch of 10 Assays from its joint venture with Daan Gene .
Together with Life Technologies’ genetic analyzer 3500 Dx that was approved by SFDA for IVD use in 2011 in China, the 3500 series genetic analyzers are intended for use in a wide range of applications in the process of clinical research, including de novo sequencing and mutational profiling as well as HLA typing. The newly expanded offering of both the 3500 Dx and the 3500xL Dx provides hospitals of all …
Nov. 26, 2013 Thermo Fisher Scientific Receives Clearance from the European Commission for its Acquisition of Life Technologies Nov. 07, 2013 Thermo Fisher Scientific Declares Quarterly Dividend Oct. 29, 2013 Thermo Fisher Scientific to Present at Baird’s …
The 3500 Dx Genetic Analyzers CS2 embody the commitment by Life Technologies to providing laboratories with the most trusted, versatile, and innovative tools for molecular diagnostic testing.
About Life Technologies Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences.
Life Technologies Gets FDA Clearance for 3500 Dx Genetic Analyzers Published: Feb 11, 2013 CARLSBAD, Calif. , Feb. 11, 2013 /PRNewswire/ — Life Technologies Corporation (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits.
Life’s Applied Biosystems™3500 Dx Genetic Analyzer and SeCore® kits constitute first sequence-based system cleared for HLA typing. Carlsbad, CA /PRNewswire/ – Life Technologies Corporation (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits.
CARLSBAD, Calif., Oct. 25, 2011 /PRNewswire/ — Life Technologies Corporation today announced that its Applied Biosystems 3500 Dx Genetic Analyzer has been approved by China …
Innovative. Intelligent. Intuitive. The Applied Biosystems™ 3500 Series Genetic Analyzer is designed to maintain the unsurpassed application versatility that life science researchers expect from Applied Biosystems™ instruments.
Life Technologies Corporation, a global biotechnology company, has received US Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. The development represents additional execution against the company’s strategy to …
NEW YORK (GenomeWeb News) – Life Technologies announced today regulatory approval in China for its Applied Biosystems 3500xL Dx Genetic Analyzer for clinical diagnostic use. The company also said that 10 assays from its joint venture with Daan Gene have been launched.
Applied Biosystems 3500xl Genetic Analyzer This analyzer is also fluorescence-based utilizing capillary electrophoresis for DNA sequencing and fragment analysis. The 3500xl system uses a 24-capillary array and single-line 505 nm, solid-state long-life laser for significantly improved signal uniformity.
DNA Sequencers / Genetic Analyzers Genetic analyzers are automated systems capable of sequencing DNA or analyzing fragments for a variety of applications. In capillary electrophoresis-based systems, DNA fragments bound to probes migrate through a polymer and the fluorescence emissions are measured.